Nvidia reports better-than-expected fourth-quarter earnings as revenue jumps 78% on demand for the company’s artificial-intelligence chips, shares of Super Micro slump, Snowflake surges as it issues upbeat fiscal-year revenue guidance, and Moderna falls on a report that HHS is reviewing the company’s bird flu vaccine contract.
